Hirotsu Bio Science Inc. announced that it has received ¥1.4 billion in its equity round of funding on July 23, 2018. The transaction included participation from AS ONE Corporation (TSE:7476), Iyo Venture Fund No. 5 Investment Limited Partnership, a fund managed by Iyogin Capital Co.

Ltd., Ehime Venture 2013 Investment Enterprise, L.P., a fund managed by Future Venture Capital Co., Ltd. (JASDAQ:8462), Ichinen Holdings Co., Ltd. (TSE:9619), Miraca Holdings Inc. (TSE:4544), Avex Inc. (TSE:7860), Toppan Forms Co., Ltd. (TSE:7862), and Nippon Broadcasting System, Inc. As One Corp. (TSE:7476) invested ¥300 million in transaction for 5% stake in the company. The company has received funds through third party allotment.